United States Renal Data System: 2019 USRDS annual data report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2019
United States Renal Data System: 2019 USRDS annual data report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2019)| false
HamodaRE, McPhersonLJ, LipfordK, Jacob ArriolaK, PlantingaL, GanderJC, et al.: Association of sociocultural factors with initiation of the kidney transplant evaluation process. Am J Transplant20: 190–203, 202010.1111/ajt.15526PubMed
HamodaRE, McPhersonLJ, LipfordK, Jacob ArriolaK, PlantingaL, GanderJC, : Association of sociocultural factors with initiation of the kidney transplant evaluation process. Am J Transplant 20: 190–203, 202010.1111/ajt.15526PubMed)| false
GillJS, HendrenE, DongJ, JohnstonO, GillJ: Differential association of body mass index with access to kidney transplantation in men and women. Clin J Am Soc Nephrol9: 951–959, 201410.2215/cjn.08310813PubMed
GillJS, HendrenE, DongJ, JohnstonO, GillJ: Differential association of body mass index with access to kidney transplantation in men and women. Clin J Am Soc Nephrol 9: 951–959, 201410.2215/cjn.08310813PubMed)| false
GargPP, FurthSL, FivushBA, PoweNR: Impact of gender on access to the renal transplant waiting list for pediatric and adult patients. J Am Soc Nephrol11: 958–964, 200010.1681/asn.V115958PubMed
GargPP, FurthSL, FivushBA, PoweNR: Impact of gender on access to the renal transplant waiting list for pediatric and adult patients. J Am Soc Nephrol 11: 958–964, 200010.1681/asn.V115958PubMed)| false
AhearnP, JohansenKL, TanJC, McCullochCE, GrimesBA, KuE: Sex disparity in deceased-donor kidney transplant access by cause of kidney disease. Clin J Am Soc Nephrol16: 241–250, 202110.2215/CJN.09140620PubMed
AhearnP, JohansenKL, TanJC, McCullochCE, GrimesBA, KuE: Sex disparity in deceased-donor kidney transplant access by cause of kidney disease. Clin J Am Soc Nephrol 16: 241–250, 202110.2215/CJN.09140620PubMed)| false
KingKL, HusainSA, JinZ, BrennanC, MohanS: Trends in disparities in preemptive kidney transplantation in the United States. Clin J Am Soc Nephrol14: 1500–1511, 201910.2215/CJN.03140319PubMed
KingKL, HusainSA, JinZ, BrennanC, MohanS: Trends in disparities in preemptive kidney transplantation in the United States. Clin J Am Soc Nephrol 14: 1500–1511, 201910.2215/CJN.03140319PubMed)| false
KuE, McCullochCE, AdeyDB, LiL, JohansenKL: Racial disparities in eligibility for preemptive waitlisting for kidney transplantation and modification of eGFR thresholds to equalize waitlist time. J Am Soc Nephrol32: 677–685, 202110.1681/asn.2020081144PubMed
KuE, McCullochCE, AdeyDB, LiL, JohansenKL: Racial disparities in eligibility for preemptive waitlisting for kidney transplantation and modification of eGFR thresholds to equalize waitlist time. J Am Soc Nephrol 32: 677–685, 202110.1681/asn.2020081144PubMed)| false
ScholdJD, AugustineJJ, HumlAM, O’TooleJ, SedorJR, PoggioED: Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant20: 769–778, 202010.1111/ajt.15646PubMed
ScholdJD, AugustineJJ, HumlAM, O’TooleJ, SedorJR, PoggioED: Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant 20: 769–778, 202010.1111/ajt.15646PubMed)| false
WatermanAD, PeipertJD, CuiY, BeaumontJL, PaivaA, LipseyAF, et al.: Your path to transplant: A randomized controlled trial of a tailored expert system intervention to increase knowledge, attitudes, and pursuit of kidney transplant. Am J Transplant21: 1186–1196, 202110.1111/ajt.16262PubMed
WatermanAD, PeipertJD, CuiY, BeaumontJL, PaivaA, LipseyAF, : Your path to transplant: A randomized controlled trial of a tailored expert system intervention to increase knowledge, attitudes, and pursuit of kidney transplant. Am J Transplant 21: 1186–1196, 202110.1111/ajt.16262PubMed)| false
ScholdJD, MohanS, HumlA, BucciniLD, SedorJR, AugustineJJ, et al.: Failure to advance access to kidney transplantation over two decades in the United States. J Am Soc Nephrol32: 913–926, 202110.1681/asn.2020060888PubMed
ScholdJD, MohanS, HumlA, BucciniLD, SedorJR, AugustineJJ, : Failure to advance access to kidney transplantation over two decades in the United States. J Am Soc Nephrol 32: 913–926, 202110.1681/asn.2020060888PubMed)| false
EneanyaND, YangW, ReesePP: Reconsidering the consequences of using race to estimate kidney function. JAMA322: 113–114, 201910.1001/jama.2019.5774PubMed
EneanyaND, YangW, ReesePP: Reconsidering the consequences of using race to estimate kidney function. JAMA 322: 113–114, 201910.1001/jama.2019.5774PubMed)| false
ZelnickLR, LecaN, YoungB, BansalN: Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open4: e2034004, 202110.1001/jamanetworkopen.2020.34004PubMed
ZelnickLR, LecaN, YoungB, BansalN: Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open 4: e2034004, 202110.1001/jamanetworkopen.2020.34004PubMed)| false
LeveyAS, TighiouartH, TitanSM, InkerLA: Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med180: 793–795, 202010.1001/jamainternmed.2020.0045PubMed
LeveyAS, TighiouartH, TitanSM, InkerLA: Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med 180: 793–795, 202010.1001/jamainternmed.2020.0045PubMed)| false
DelgadoC, BawejaM, BurrowsNR, CrewsDC, EneanyaND, GadegbekuCA, et al.: Reassessing the inclusion of race in diagnosing kidney diseases: An interim report from the NKF-ASN task force. Am J Kidney Dis78: 103–115, 202110.1053/j.ajkd.2021.03.008PubMed
DelgadoC, BawejaM, BurrowsNR, CrewsDC, EneanyaND, GadegbekuCA, : Reassessing the inclusion of race in diagnosing kidney diseases: An interim report from the NKF-ASN task force. Am J Kidney Dis 78: 103–115, 202110.1053/j.ajkd.2021.03.008PubMed)| false
BangaloreS, MaronDJ, O’BrienSM, FlegJL, KretovEI, BriguoriC, et al.; ISCHEMIA-CKD Research Group: Management of coronary disease in patients with advanced kidney disease. N Engl J Med382: 1608–1618, 202010.1056/NEJMoa1915925PubMed
BangaloreS, MaronDJ, O’BrienSM, FlegJL, KretovEI, BriguoriC, ; ISCHEMIA-CKD Research Group: Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382: 1608–1618, 202010.1056/NEJMoa1915925PubMed)| false
SpertusJA, JonesPG, MaronDJ, MarkDB, O’BrienSM, FlegJL, et al.; ISCHEMIA-CKD Research Group: Health status after invasive or conservative care in coronary and advanced kidney disease. N Engl J Med382: 1619–1628, 202010.1056/NEJMoa1916374PubMed
SpertusJA, JonesPG, MaronDJ, MarkDB, O’BrienSM, FlegJL, ; ISCHEMIA-CKD Research Group: Health status after invasive or conservative care in coronary and advanced kidney disease. N Engl J Med 382: 1619–1628, 202010.1056/NEJMoa1916374PubMed)| false
HeybeliC, BentallA, WenJ, AlexanderMP, BuadiFK, CosioFG, et al.: A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int99: 707–715, 202110.1016/j.kint.2020.06.036PubMed
HeybeliC, BentallA, WenJ, AlexanderMP, BuadiFK, CosioFG, : A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int 99: 707–715, 202110.1016/j.kint.2020.06.036PubMed)| false
Angel-KormanA, SternL, SarosiekS, SloanJM, DorosG, SanchorawalaV, et al.: Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int95: 405–411, 201910.1016/j.kint.2018.09.021PubMed
Angel-KormanA, SternL, SarosiekS, SloanJM, DorosG, SanchorawalaV, : Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int 95: 405–411, 201910.1016/j.kint.2018.09.021PubMed)| false
LeeaphornN, ThongprayoonC, ChewcharatA, HansrivijitP, JadlowiecCC, CummingsLS, et al.: Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000-2019 UNOS/OPTN database. Am J Transplant21: 846–853, 202110.1111/ajt.16385PubMed
LeeaphornN, ThongprayoonC, ChewcharatA, HansrivijitP, JadlowiecCC, CummingsLS, : Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000-2019 UNOS/OPTN database. Am J Transplant 21: 846–853, 202110.1111/ajt.16385PubMed)| false
GershenwaldJE, ScolyerRA, HessKR, SondakVK, LongGV, RossMI, et al.; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform: Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin67: 472–492, 201710.3322/caac.21409PubMed
GershenwaldJE, ScolyerRA, HessKR, SondakVK, LongGV, RossMI, ; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform: Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67: 472–492, 201710.3322/caac.21409PubMed)| false
Al-AdraDP, HammelL, RobertsJ, WoodleES, LevineD, MandelbrotD, et al.: Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant21: 475–483, 202110.1111/ajt.16324PubMed
Al-AdraDP, HammelL, RobertsJ, WoodleES, LevineD, MandelbrotD, : Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant 21: 475–483, 202110.1111/ajt.16324PubMed)| false
Al-AdraDP, HammelL, RobertsJ, WoodleES, LevineD, MandelbrotD, et al.: Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant21: 460–474, 202110.1111/ajt.16318PubMed
Al-AdraDP, HammelL, RobertsJ, WoodleES, LevineD, MandelbrotD, : Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant 21: 460–474, 202110.1111/ajt.16318PubMed)| false
OttlewskiI, MünchJ, WagnerT, SchönauerR, BachmannA, WeimannA, et al.: Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int96: 222–230, 201910.1016/j.kint.2019.01.038PubMed
OttlewskiI, MünchJ, WagnerT, SchönauerR, BachmannA, WeimannA, : Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int 96: 222–230, 201910.1016/j.kint.2019.01.038PubMed)| false
MannN, BraunDA, AmannK, TanW, ShrilS, ConnaughtonDM, et al.: Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol30: 201–215, 201910.1681/asn.2018060575PubMed
MannN, BraunDA, AmannK, TanW, ShrilS, ConnaughtonDM, : Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol 30: 201–215, 201910.1681/asn.2018060575PubMed)| false
ZuberJ, FrimatM, CaillardS, KamarN, GataultP, PetitprezF, et al.: Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol30: 2449–2463, 201910.1681/asn.2019040331PubMed
ZuberJ, FrimatM, CaillardS, KamarN, GataultP, PetitprezF, : Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol 30: 2449–2463, 201910.1681/asn.2019040331PubMed)| false
LadinK, DanielsA, OsaniM, BannuruRR: Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando)32: 16–28, 201810.1016/j.trre.2017.04.001PubMed
LadinK, DanielsA, OsaniM, BannuruRR: Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando) 32: 16–28, 201810.1016/j.trre.2017.04.001PubMed)| false
LadinK, EmersonJ, BerryK, ButtZ, GordonEJ, DanielsN, et al.: Excluding patients from transplant due to social support: Results from a national survey of transplant providers. Am J Transplant19: 193–203, 201910.1111/ajt.14962PubMed
LadinK, EmersonJ, BerryK, ButtZ, GordonEJ, DanielsN, : Excluding patients from transplant due to social support: Results from a national survey of transplant providers. Am J Transplant 19: 193–203, 201910.1111/ajt.14962PubMed)| false
NghiemDM, GomezJ, GlostonGF, TorresDS, MarekRJ: Psychological assessment instruments for use in liver and kidney transplant evaluations: Scarcity of evidence and recommendations. J Pers Assess102: 183–195, 202010.1080/00223891.2019.1694527PubMed
NghiemDM, GomezJ, GlostonGF, TorresDS, MarekRJ: Psychological assessment instruments for use in liver and kidney transplant evaluations: Scarcity of evidence and recommendations. J Pers Assess 102: 183–195, 202010.1080/00223891.2019.1694527PubMed)| false
PuttarajappaCM, SchinstockCA, WuCM, LecaN, KumarV, VasudevBS, et al.: KDOQI US commentary on the 2020 KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Am J Kidney Dis77: 833–856, 202110.1053/j.ajkd.2020.11.017PubMed
PuttarajappaCM, SchinstockCA, WuCM, LecaN, KumarV, VasudevBS, : KDOQI US commentary on the 2020 KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Am J Kidney Dis 77: 833–856, 202110.1053/j.ajkd.2020.11.017PubMed)| false
ChadbanSJ, AhnC, AxelrodDA, et al.: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation104: S11–S103, 202010.1097/tp.0000000000003136
ChadbanSJ, AhnC, AxelrodDA, : KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation 104: S11–S103, 202010.1097/tp.0000000000003136)| false
HuckerA, LawrenceC, SharmaS, FarringtonK: Adherence behavior in subjects on hemodialysis is not a clear predictor of posttransplantation adherence. Kidney Int Rep4: 1122–1130, 201910.1016/j.ekir.2019.04.028PubMed
HuckerA, LawrenceC, SharmaS, FarringtonK: Adherence behavior in subjects on hemodialysis is not a clear predictor of posttransplantation adherence. Kidney Int Rep 4: 1122–1130, 201910.1016/j.ekir.2019.04.028PubMed)| false
GillJS, SchaeffnerE, ChadbanS, DongJ, RoseC, JohnstonO, et al.: Quantification of the early risk of death in elderly kidney transplant recipients. Am J Transplant13: 427–432, 201310.1111/j.1600-6143.2012.04323.xPubMed
GillJS, SchaeffnerE, ChadbanS, DongJ, RoseC, JohnstonO, : Quantification of the early risk of death in elderly kidney transplant recipients. Am J Transplant 13: 427–432, 201310.1111/j.1600-6143.2012.04323.xPubMed)| false
LegeaiC, AndrianasoloRM, MoranneO, SnanoudjR, HourmantM, BauwensM, et al.: Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy. Am J Transplant18: 2695–2707, 201810.1111/ajt.15110PubMed
LegeaiC, AndrianasoloRM, MoranneO, SnanoudjR, HourmantM, BauwensM, : Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy. Am J Transplant 18: 2695–2707, 201810.1111/ajt.15110PubMed)| false
CabreraJ, Fernández-RuizM, TrujilloH, GonzálezE, MolinaM, PolancoN, et al.: Kidney transplantation in the extremely elderly from extremely aged deceased donors: a kidney for each age. Nephrol Dial Transplant35: 687–696, 202010.1093/ndt/gfz293PubMed
CabreraJ, Fernández-RuizM, TrujilloH, GonzálezE, MolinaM, PolancoN, : Kidney transplantation in the extremely elderly from extremely aged deceased donors: a kidney for each age. Nephrol Dial Transplant 35: 687–696, 202010.1093/ndt/gfz293PubMed)| false
BaeS, MassieAB, ThomasAG, BahnG, LuoX, JacksonKR, et al.: Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination. Am J Transplant19: 425–433, 201910.1111/ajt.14978PubMed
BaeS, MassieAB, ThomasAG, BahnG, LuoX, JacksonKR, : Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination. Am J Transplant 19: 425–433, 201910.1111/ajt.14978PubMed)| false
HellemansR, JagerKJ, AbramowiczD: Transplantation in older individuals: Is it really better than dialysis?Curr Opin Organ Transplant25: 86–91, 202010.1097/mot.0000000000000723PubMed
HellemansR, JagerKJ, AbramowiczD: Transplantation in older individuals: Is it really better than dialysis?Curr Opin Organ Transplant 25: 86–91, 202010.1097/mot.0000000000000723PubMed)| false
LynchRJ, PatzerRE, PastanSO, BowlingCB, PlantingaLC: Recent history of serious fall injuries and posttransplant outcomes among US kidney transplant recipients. Transplantation103: 1043–1050, 201910.1097/TP.0000000000002463PubMed
LynchRJ, PatzerRE, PastanSO, BowlingCB, PlantingaLC: Recent history of serious fall injuries and posttransplant outcomes among US kidney transplant recipients. Transplantation 103: 1043–1050, 201910.1097/TP.0000000000002463PubMed)| false
ChuNM, GrossAL, ShafferAA, HaugenCE, NormanSP, XueQL, et al.: Frailty and changes in cognitive function after kidney transplantation. J Am Soc Nephrol30: 336–345, 201910.1681/ASN.2018070726PubMed
ChuNM, GrossAL, ShafferAA, HaugenCE, NormanSP, XueQL, : Frailty and changes in cognitive function after kidney transplantation. J Am Soc Nephrol 30: 336–345, 201910.1681/ASN.2018070726PubMed)| false
BuiK, KilambiV, RodrigueJR, MehrotraS: Patient functional status at transplant and its impact on posttransplant survival of adult deceased-donor kidney recipients. Transplantation103: 1051–1063, 201910.1097/TP.0000000000002397PubMed
BuiK, KilambiV, RodrigueJR, MehrotraS: Patient functional status at transplant and its impact on posttransplant survival of adult deceased-donor kidney recipients. Transplantation 103: 1051–1063, 201910.1097/TP.0000000000002397PubMed)| false
McAdams-DeMarcoMA, YingH, Van Pilsum RasmussenS, SchrackJ, HaugenCE, ChuNM, et al.: Prehabilitation prior to kidney transplantation: Results from a pilot study. Clin Transplant33: e13450, 201910.1111/ctr.13450PubMed
McAdams-DeMarcoMA, YingH, Van Pilsum RasmussenS, SchrackJ, HaugenCE, ChuNM, : Prehabilitation prior to kidney transplantation: Results from a pilot study. Clin Transplant 33: e13450, 201910.1111/ctr.13450PubMed)| false
KobashigawaJ, DadhaniaD, BhoradeS, AdeyD, BergerJ, BhatG, et al.: Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant19: 984–994, 201910.1111/ajt.15198PubMed
KobashigawaJ, DadhaniaD, BhoradeS, AdeyD, BergerJ, BhatG, : Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant 19: 984–994, 201910.1111/ajt.15198PubMed)| false
SheetzKH, GerhardingerL, DimickJB, WaitsSA: Bariatric surgery and long-term survival in patients with obesity and end-stage kidney disease. JAMA Surg155: 581–588, 202010.1001/jamasurg.2020.0829PubMed
SheetzKH, GerhardingerL, DimickJB, WaitsSA: Bariatric surgery and long-term survival in patients with obesity and end-stage kidney disease. JAMA Surg 155: 581–588, 202010.1001/jamasurg.2020.0829PubMed)| false
SheetzKH, WoodsideKJ, ShahinianVB, DimickJB, MontgomeryJR, WaitsSA: Trends in bariatric surgery procedures among patients with ESKD in the United States. Clin J Am Soc Nephrol14: 1193–1199, 201910.2215/CJN.01480219PubMed
SheetzKH, WoodsideKJ, ShahinianVB, DimickJB, MontgomeryJR, WaitsSA: Trends in bariatric surgery procedures among patients with ESKD in the United States. Clin J Am Soc Nephrol 14: 1193–1199, 201910.2215/CJN.01480219PubMed)| false
KassamAF, MirzaA, KimY, HansemanD, WoodleES, QuillinRC3rd et al.: Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant20: 422–429, 202010.1111/ajt.15650PubMed
KassamAF, MirzaA, KimY, HansemanD, WoodleES, QuillinRC3rd: Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant 20: 422–429, 202010.1111/ajt.15650PubMed)| false
SpaggiariM, Di CoccoP, TullaK, KaylanKB, MasrurMA, HassanC, et al.: Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant21: 1525–1534, 202110.1111/ajt.16322PubMed
SpaggiariM, Di CoccoP, TullaK, KaylanKB, MasrurMA, HassanC, : Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant 21: 1525–1534, 202110.1111/ajt.16322PubMed)| false
TourretJ, GuiguetM, LassalleM, GrabarS, LièvreL, Isnard-BagnisC, et al.: Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study. Am J Transplant19: 3345–3355, 201910.1111/ajt.15500PubMed
TourretJ, GuiguetM, LassalleM, GrabarS, LièvreL, Isnard-BagnisC, : Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study. Am J Transplant 19: 3345–3355, 201910.1111/ajt.15500PubMed)| false
DurandCM, ZhangW, BrownDM, YuS, DesaiN, ReddAD, et al.; HOPE in Action Investigators: A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant21: 1754–1764, 202110.1111/ajt.16205PubMed
DurandCM, ZhangW, BrownDM, YuS, DesaiN, ReddAD, ; HOPE in Action Investigators: A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant 21: 1754–1764, 202110.1111/ajt.16205PubMed)| false
MolnarMZ, AzharA, TsujitaM, TalwarM, BalaramanV, BhallaA, et al.: Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: One-year kidney allograft outcomes. Am J Kidney Dis77: 739–747.e1, 202110.1053/j.ajkd.2020.10.017PubMed
MolnarMZ, AzharA, TsujitaM, TalwarM, BalaramanV, BhallaA, : Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: One-year kidney allograft outcomes. Am J Kidney Dis 77: 739–747.e1, 202110.1053/j.ajkd.2020.10.017PubMed)| false
ChangSH, MerzkaniM, LentineKL, WangM, AxelrodDA, AnwarS, et al.: Trends in discard of kidneys from hepatitis C viremic donors in the United States. Clin J Am Soc Nephrol16: 251–261, 202110.2215/CJN.10960720PubMed
ChangSH, MerzkaniM, LentineKL, WangM, AxelrodDA, AnwarS, : Trends in discard of kidneys from hepatitis C viremic donors in the United States. Clin J Am Soc Nephrol 16: 251–261, 202110.2215/CJN.10960720PubMed)| false
EckmanMH, WoodleES, ThakarCV, AllowayRR, ShermanKE: Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients. Am J Kidney Dis75: 857–867, 202010.1053/j.ajkd.2019.11.005PubMed
EckmanMH, WoodleES, ThakarCV, AllowayRR, ShermanKE: Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients. Am J Kidney Dis 75: 857–867, 202010.1053/j.ajkd.2019.11.005PubMed)| false
FridellJA, NiederhausS, CurryM, UrbanR, FoxA, OdoricoJ: The survival advantage of pancreas after kidney transplant. Am J Transplant19: 823–830, 201910.1111/ajt.15106PubMed
FridellJA, NiederhausS, CurryM, UrbanR, FoxA, OdoricoJ: The survival advantage of pancreas after kidney transplant. Am J Transplant 19: 823–830, 201910.1111/ajt.15106PubMed)| false
PhamPH, StalterLN, MartinezEJ, Wang JF, Welch BM, Leverson G, et al.: Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes. Am J Transplant21: 2810–2823, 202010.1111/ajt.16462PubMed
PhamPH, StalterLN, MartinezEJ, Wang JF, Welch BM, Leverson G, : Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes. Am J Transplant 21: 2810–2823, 202010.1111/ajt.16462PubMed)| false
LonzeBE, BaptisteG, AliNM, DagherNN, GelbBE, MattooA, et al.: Pancreas transplantation from hepatitis C viremic donors to uninfected recipients. Am J Transplant21: 1931–1936, 202110.1111/ajt.16465PubMed
LonzeBE, BaptisteG, AliNM, DagherNN, GelbBE, MattooA, : Pancreas transplantation from hepatitis C viremic donors to uninfected recipients. Am J Transplant 21: 1931–1936, 202110.1111/ajt.16465PubMed)| false
WilkAR, BookerSE, StewartDE, WisemanA, GaunttK, MulliganD, et al.: Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy. Am J Transplant21: 3593–3607, 202110.1111/ajt.16761PubMed
WilkAR, BookerSE, StewartDE, WisemanA, GaunttK, MulliganD, : Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN’s allocation policy. Am J Transplant 21: 3593–3607, 202110.1111/ajt.16761PubMed)| false
AltshulerPJ, ShahAP, FrankAM, GloriosoJ, DangH, ShaheenO, et al.: Simultaneous liver kidney allocation policy and the safety net: An early examination of utilization and outcomes in the United States. Transpl Int34: 1052–1064, 202110.1111/tri.13891PubMed
AltshulerPJ, ShahAP, FrankAM, GloriosoJ, DangH, ShaheenO, : Simultaneous liver kidney allocation policy and the safety net: An early examination of utilization and outcomes in the United States. Transpl Int 34: 1052–1064, 202110.1111/tri.13891PubMed)| false
ShawBI, SamoylovaML, SanoffS, BarbasAS, SudanDL, BoulwareLE, et al.: Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate. Am J Transplant21: 2468–2478, 202110.1111/ajt.16466PubMed
ShawBI, SamoylovaML, SanoffS, BarbasAS, SudanDL, BoulwareLE, : Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate. Am J Transplant 21: 2468–2478, 202110.1111/ajt.16466PubMed)| false
MelvinsdottirI, FoleyDP, HessT, GunnarssonSI, KohmotoT, HermsenJ, et al.: Heart and kidney transplant: Should they be combined or subsequent?ESC Heart Fail7: 2734–2743, 202010.1002/ehf2.12864PubMed
MelvinsdottirI, FoleyDP, HessT, GunnarssonSI, KohmotoT, HermsenJ, : Heart and kidney transplant: Should they be combined or subsequent?ESC Heart Fail 7: 2734–2743, 202010.1002/ehf2.12864PubMed)| false
WestphalSG, LangewischED, RobinsonAM, WilkAR, DongJJ, PlumbTJ, et al.: The impact of multi-organ transplant allocation priority on waitlisted kidney transplant candidates. Am J Transplant21: 2161–2174, 202110.1111/ajt.16390PubMed
WestphalSG, LangewischED, RobinsonAM, WilkAR, DongJJ, PlumbTJ, : The impact of multi-organ transplant allocation priority on waitlisted kidney transplant candidates. Am J Transplant 21: 2161–2174, 202110.1111/ajt.16390PubMed)| false
NanayakkaraDD, SchaenmanJ: Screening of donors and recipients for infections prior to solid organ transplantation. Curr Opin Organ Transplant24: 456–464, 201910.1097/mot.0000000000000671PubMed
NanayakkaraDD, SchaenmanJ: Screening of donors and recipients for infections prior to solid organ transplantation. Curr Opin Organ Transplant 24: 456–464, 201910.1097/mot.0000000000000671PubMed)| false
MalinisM, BoucherHW; AST Infectious Diseases Community of Practice: Screening of donor and candidate prior to solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant33: e13548, 201910.1111/ctr.13548PubMed
MalinisM, BoucherHW; AST Infectious Diseases Community of Practice: Screening of donor and candidate prior to solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33: e13548, 201910.1111/ctr.13548PubMed)| false
SterlingTR, NjieG, ZennerD, CohnDL, RevesR, AhmedA, et al.: Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep69: 1–11, 202010.15585/mmwr.rr6901a1PubMed
SterlingTR, NjieG, ZennerD, CohnDL, RevesR, AhmedA, : Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 69: 1–11, 202010.15585/mmwr.rr6901a1PubMed)| false
